Heartbeam Stock Today

BEAT Stock  USD 2.05  0.03  1.49%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Very High

 
High
 
Low
Heartbeam is selling for under 2.05 as of the 16th of March 2025; that is 1.49 percent increase since the beginning of the trading day. The stock's last reported lowest price was 2.0. Heartbeam has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 16th of December 2024 and ending today, the 16th of March 2025. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
11th of November 2021
Category
Healthcare
Classification
Health Care
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company was incorporated in 2015 and is headquartered in Santa Clara, California. The company has 33.73 M outstanding shares of which 218.51 K shares are currently shorted by private and institutional investors with about 1.8 trading days to cover. More on Heartbeam

Moving against Heartbeam Stock

  0.48LUNG Pulmonx CorpPairCorr
  0.41BAX Baxter InternationalPairCorr
  0.31CCLDP CareCloud Earnings Call This WeekPairCorr

Heartbeam Stock Highlights

ESG Sustainability
Environmental
Governance
Social
Executive ChairmanRichard Ferrari
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, NASDAQ Composite Total, Health Care, Health Care Equipment & Supplies, Health Information Services, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.820.61
Significantly Up
Slightly volatile
Gross Profit Margin0.460.56
Significantly Down
Pretty Stable
Total Current LiabilitiesM1.1 M
Notably Down
Slightly volatile
Total Assets3.1 M3.3 M
Notably Down
Pretty Stable
Total Current Assets2.6 M2.8 M
Notably Down
Slightly volatile
Debt Levels
Heartbeam can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Heartbeam's financial leverage. It provides some insight into what part of Heartbeam's total assets is financed by creditors.
Liquidity
Heartbeam currently holds 1.62 M in liabilities with Debt to Equity (D/E) ratio of 0.52, which is about average as compared to similar companies. Heartbeam has a current ratio of 12.4, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Heartbeam's use of debt, we should always consider it together with its cash and equity.

Total Cash From Operating Activities

(13.75 Million)
Heartbeam (BEAT) is traded on NASDAQ Exchange in USA. It is located in 2118 Walsh Avenue, Santa Clara, CA, United States, 95050 and employs 20 people. Heartbeam is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 69.14 M. Heartbeam conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 33.73 M outstanding shares of which 218.51 K shares are currently shorted by private and institutional investors with about 1.8 trading days to cover. Heartbeam currently holds about 9.27 M in cash with (14.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.16.
Check Heartbeam Probability Of Bankruptcy
Ownership Allocation
Heartbeam has a total of 33.73 Million outstanding shares. Heartbeam secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Heartbeam Ownership Details

Heartbeam Stock Institutional Holders

InstituionRecorded OnShares
Blackrock Inc2024-12-31
74.8 K
Spectrum Asset Management Inc2024-12-31
74.4 K
Advisory Research Inc2024-12-31
50 K
Northern Trust Corp2024-12-31
49.5 K
Susquehanna International Group, Llp2024-12-31
43.6 K
D'orazio & Associates Inc2024-12-31
33 K
Smart Wealth Llc2024-12-31
25 K
Lpl Financial Corp2024-12-31
21.7 K
Charles Schwab Investment Management Inc2024-12-31
14.5 K
Vanguard Group Inc2024-12-31
763.7 K
Smith, Salley & Associates, Llc2024-12-31
250 K
View Heartbeam Diagnostics

Heartbeam Historical Income Statement

At this time, Heartbeam's Gross Profit is comparatively stable compared to the past year. Cost Of Revenue is likely to gain to about 199 M in 2025, whereas Other Operating Expenses is likely to drop slightly above 13.1 M in 2025. View More Fundamentals

Heartbeam Stock Against Markets

Heartbeam Corporate Management

Additional Tools for Heartbeam Stock Analysis

When running Heartbeam's price analysis, check to measure Heartbeam's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heartbeam is operating at the current time. Most of Heartbeam's value examination focuses on studying past and present price action to predict the probability of Heartbeam's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heartbeam's price. Additionally, you may evaluate how the addition of Heartbeam to your portfolios can decrease your overall portfolio volatility.